LifeStance Health Group, Inc.
LFST
$7.59
-$0.29-3.68%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.25B | 1.21B | 1.16B | 1.10B | 1.06B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.25B | 1.21B | 1.16B | 1.10B | 1.06B |
| Cost of Revenue | 848.57M | 829.82M | 804.21M | 776.29M | 753.57M |
| Gross Profit | 402.40M | 376.28M | 352.06M | 327.22M | 302.10M |
| SG&A Expenses | 361.83M | 352.59M | 351.00M | 352.03M | 347.71M |
| Depreciation & Amortization | 70.95M | 78.50M | 83.00M | 83.93M | 80.44M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.28B | 1.26B | 1.24B | 1.21B | 1.18B |
| Operating Income | -30.38M | -54.81M | -81.95M | -108.74M | -126.05M |
| Income Before Tax | -57.61M | -87.05M | -159.64M | -189.04M | -206.58M |
| Income Tax Expenses | -170.00K | 8.24M | -8.72M | -15.92M | -20.32M |
| Earnings from Continuing Operations | -57.44 | -95.29 | -150.92 | -173.12 | -186.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.44M | -95.29M | -150.92M | -173.12M | -186.26M |
| EBIT | -30.38M | -54.81M | -81.95M | -108.74M | -126.05M |
| EBITDA | 40.57M | 23.69M | 1.06M | -24.81M | -45.61M |
| EPS Basic | -0.15 | -0.26 | -0.41 | -0.47 | -0.51 |
| Normalized Basic EPS | -0.09 | -0.13 | -0.18 | -0.22 | -0.25 |
| EPS Diluted | -0.15 | -0.26 | -0.41 | -0.47 | -0.51 |
| Normalized Diluted EPS | -0.09 | -0.13 | -0.18 | -0.22 | -0.25 |
| Average Basic Shares Outstanding | 1.52B | 1.50B | 1.50B | 1.48B | 1.46B |
| Average Diluted Shares Outstanding | 1.52B | 1.50B | 1.50B | 1.48B | 1.46B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
